Authors: Rencher, SD Lockey, TD Srinivas, RV Owens, RJ Hurwitz, JL

Citation: Sd. Rencher et al., Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants (vol 15, pg 265, 1997), VACCINE, 18(18), 2000, pp. 1969-1969

Authors: Srinivas, RV

Citation: Rv. Srinivas, May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors? Author's reply, ANTIM AG CH, 44(2), 2000, pp. 474-474

Authors: Schuetz, JD Connelly, MC Sun, DX Paibir, SG Flynn, PM Srinivas, RV Kumar, A Fridland, A

Citation: Jd. Schuetz et al., MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs, NAT MED, 5(9), 1999, pp. 1048-1051

Authors: Caver, TE Lockey, TD Srinivas, RV Webster, RG Hurwitz, JL

Citation: Te. Caver et al., A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation, VACCINE, 17(11-12), 1999, pp. 1567-1572

Authors: Srinivas, RV Middlemas, D Flynn, P Fridland, A

Citation: Rv. Srinivas et al., Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters, ANTIM AG CH, 42(12), 1998, pp. 3157-3162